| Followers | 0 |
| Posts | 6673 |
| Boards Moderated | 0 |
| Alias Born | 01/28/2011 |
Wednesday, January 11, 2012 6:19:59 PM
I appreciate your opinion, but I read every post on this board and I know every poster. I even check to see if they have posted before. Go back and look at all the posters who mysteriously showed up at the same time who had never posted before.
Was this a bear raid to cover short positions? To pick up more cheapies? I can't answer that question, but there is no doubt this was a concerted effort to drive down the price. Heck, a couple of the posters showed up an hour before hand and called the time it would drop.
I'm not dreaming, but it doesn't really matter. Everyone is entitled to their opinion.
Thanks for the great chart video. You always do a great job.
Good luck to all in ATRN!
Was this a bear raid to cover short positions? To pick up more cheapies? I can't answer that question, but there is no doubt this was a concerted effort to drive down the price. Heck, a couple of the posters showed up an hour before hand and called the time it would drop.
I'm not dreaming, but it doesn't really matter. Everyone is entitled to their opinion.
Thanks for the great chart video. You always do a great job.
Good luck to all in ATRN!
If you have patience, follow me to Patient Profitable Picks:
http://investorshub.advfn.com/boards/board.aspx?board_id=23041
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
